{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:41Z","timestamp":1792783121465,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Deanship of Graduate Studies and Scientific Research at Jouf University","award":["DGSSR-2025-01-01564"],"award-info":[{"award-number":["DGSSR-2025-01-01564"]}],"id":[{"id":"https:\/\/ror.org\/02zsyt821","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11543-0","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T10:51:13Z","timestamp":1776595873000},"page":"7929-7952","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quinazoline-sulfonamide hybrids as multitarget anticancer agents: inhibition of carbonic anhydrase IX\/XII isoforms and VEGFR-2 with in vitro and in silico validation"],"prefix":"10.1007","volume":"30","author":[{"given":"Mohamed A.","family":"Zeidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad M.","family":"Al-Sanea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed R.","family":"Elnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed W.","family":"El-Shafey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar S.","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"issue":"1","key":"11543_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01856-7","volume":"9","author":"B Liu","year":"2024","unstructured":"Liu B, Zhou H, Tan L, Siu KTH, Guan X-Y (2024) Exploring treatment options in cancer: tumor treatment strategies. Signal Transduct Target Ther 9(1):175. https:\/\/doi.org\/10.1038\/s41392-024-01856-7","journal-title":"Signal Transduct Target Ther"},{"key":"11543_CR2","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.ejmech.2017.10.021","volume":"143","author":"NM Raghavendra","year":"2018","unstructured":"Raghavendra NM, Pingili D, Kadasi S, Mettu A, Prasad SVUM (2018) Dual or multi-targeting inhibitors: the next generation anticancer agents. Eur J Med Chem 143:1277\u20131300. https:\/\/doi.org\/10.1016\/j.ejmech.2017.10.021","journal-title":"Eur J Med Chem"},{"key":"11543_CR3","volume":"6","author":"S Chakraborty","year":"2012","unstructured":"Chakraborty S, Rahman T (2012) The difficulties in cancer treatment. ecancermedicalscience 6:ed16","journal-title":"ecancermedicalscience"},{"issue":"4","key":"11543_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","volume":"26","author":"P Csermely","year":"2005","unstructured":"Csermely P, \u00c1goston V, Pongor S (2005) The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 26(4):178\u2013182. https:\/\/doi.org\/10.1016\/j.tips.2005.02.007","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"11543_CR5","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1002\/med.22057","volume":"44","author":"Y Yang","year":"2024","unstructured":"Yang Y, Mou Y, Wan L-X, Zhu S, Wang G, Gao H, Liu B (2024) Rethinking therapeutic strategies of dual-target drugs: an update on pharmacological small-molecule compounds in cancer. Med Res Rev 44(6):2600\u20132623. https:\/\/doi.org\/10.1002\/med.22057","journal-title":"Med Res Rev"},{"issue":"1","key":"11543_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01607-9","volume":"22","author":"A Doostmohammadi","year":"2024","unstructured":"Doostmohammadi A, Jooya H, Ghorbanian K, Gohari S, Dadashpour M (2024) Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents. Cell Commun Signal 22(1):228. https:\/\/doi.org\/10.1186\/s12964-024-01607-9","journal-title":"Cell Commun Signal"},{"key":"11543_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.112025","volume":"188","author":"D Sun","year":"2020","unstructured":"Sun D, Zhao Y, Zhang S, Zhang L, Liu B, Ouyang L (2020) Dual-target kinase drug design: current strategies and future directions in cancer therapy. Eur J Med Chem 188:112025. https:\/\/doi.org\/10.1016\/j.ejmech.2019.112025","journal-title":"Eur J Med Chem"},{"key":"11543_CR8","doi-asserted-by":"crossref","unstructured":"M. Benej, S. Pastorekova, J. Pastorek, (2013) Carbonic anhydrase IX: regulation and role in cancer, Carbonic anhydrase: mechanism, regulation, links to disease, and industrial applications. 199\u2013219","DOI":"10.1007\/978-94-007-7359-2_11"},{"issue":"14","key":"11543_CR9","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1042\/bcj20160115","volume":"473","author":"CT Supuran","year":"2016","unstructured":"Supuran CT (2016) Structure and function of carbonic anhydrases. Biochem J 473(14):2023\u20132032. https:\/\/doi.org\/10.1042\/bcj20160115","journal-title":"Biochem J"},{"issue":"41","key":"11543_CR10","doi-asserted-by":"publisher","first-page":"16825","DOI":"10.1074\/jbc.R117.799973","volume":"292","author":"H Xie","year":"2017","unstructured":"Xie H, Simon MC (2017) Oxygen availability and metabolic reprogramming in cancer. J Biol Chem 292(41):16825\u201316832. https:\/\/doi.org\/10.1074\/jbc.R117.799973","journal-title":"J Biol Chem"},{"issue":"5","key":"11543_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/sj.bjc.6603922","volume":"97","author":"RA Gatenby","year":"2007","unstructured":"Gatenby RA, Smallbone K, Maini PK, Rose F, Averill J, Nagle RB, Worrall L, Gillies RJ (2007) Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer 97(5):646\u2013653. https:\/\/doi.org\/10.1038\/sj.bjc.6603922","journal-title":"Br J Cancer"},{"issue":"2","key":"11543_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7(2):168\u2013181. https:\/\/doi.org\/10.1038\/nrd2467","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"11543_CR13","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1021\/cr200176r","volume":"112","author":"V Alterio","year":"2012","unstructured":"Alterio V, Di Fiore A, D\u2019Ambrosio K, Supuran CT, De Simone G (2012) Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 112(8):4421\u20134468. https:\/\/doi.org\/10.1021\/cr200176r","journal-title":"Chem Rev"},{"issue":"10","key":"11543_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","volume":"28","author":"A Nocentini","year":"2018","unstructured":"Nocentini A, Supuran CT (2018) Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018). Expert Opin Ther Pat 28(10):729\u2013740","journal-title":"Expert Opin Ther Pat"},{"issue":"11","key":"11543_CR15","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","volume":"14","author":"A Nocentini","year":"2019","unstructured":"Nocentini A, Supuran CT (2019) Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opin Drug Discov 14(11):1175\u20131197","journal-title":"Expert Opin Drug Discov"},{"issue":"9","key":"11543_CR16","doi-asserted-by":"publisher","first-page":"7406","DOI":"10.1021\/acs.jmedchem.4c00239","volume":"67","author":"SM Hefny","year":"2024","unstructured":"Hefny SM, El-Moselhy TF, El-Din N, Giovannuzzi S, Bin Traiki T, Vaali-Mohammed M-A, El-Dessouki AM, Yamaguchi K, Sugiura M, Shaldam MA, Supuran CT, Abdulla M-H, Eldehna WM, Tawfik HO (2024) Discovery and mechanistic studies of dual-target hits for Carbonic Anhydrase IX and VEGFR-2 as potential agents for solid tumors: X-ray, In Vitro, In Vivo, and In Silico investigations of coumarin-based thiazoles. J Med Chem 67(9):7406\u20137430. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00239","journal-title":"J Med Chem"},{"issue":"45","key":"11543_CR17","doi-asserted-by":"publisher","first-page":"33384","DOI":"10.1039\/D4RA05244G","volume":"14","author":"PJ Chaudhari","year":"2024","unstructured":"Chaudhari PJ, Nemade AR, Shirkhedkar AA (2024) Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents. RSC Adv 14(45):33384\u201333417. https:\/\/doi.org\/10.1039\/D4RA05244G","journal-title":"RSC Adv"},{"issue":"10","key":"11543_CR18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.4155\/fmc.14.68","volume":"6","author":"F Carta","year":"2014","unstructured":"Carta F, Supuran CT, Scozzafava A (2014) Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med Chem 6(10):1149\u20131165","journal-title":"Future Med Chem"},{"key":"11543_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216338","volume":"571","author":"E Andreucci","year":"2023","unstructured":"Andreucci E, Biagioni A, Peri S, Versienti G, Cianchi F, Staderini F, Antonuzzo L, Supuran CT, Olivo E, Pasqualini E, Messerini L, Massi D, Lulli M, Ruzzolini J, Peppicelli S, Bianchini F, Schiavone N, Calorini L, Magnelli L, Papucci L (2023) The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs. Cancer Lett 571:216338. https:\/\/doi.org\/10.1016\/j.canlet.2023.216338","journal-title":"Cancer Lett"},{"issue":"1","key":"11543_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1080\/14756366.2020.1764549","volume":"35","author":"S Peppicelli","year":"2020","unstructured":"Peppicelli S, Andreucci E, Ruzzolini J, Bianchini F, Nediani C, Supuran CT, Calorini L (2020) The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells. J Enzyme Inhib Med Chem 35(1):1185\u20131193. https:\/\/doi.org\/10.1080\/14756366.2020.1764549","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"15","key":"11543_CR21","doi-asserted-by":"publisher","first-page":"10558","DOI":"10.1021\/acs.jmedchem.3c00721","volume":"66","author":"AE Elsawi","year":"2023","unstructured":"Elsawi AE, Elbadawi MM, Nocentini A, Almahli H, Giovannuzzi S, Shaldam M, Salem R, Ibrahim TM, Abdel-Aziz HA, Supuran CT, Eldehna WM (2023) 1,5-Diaryl-1,2,4-triazole ureas as new SLC-0111 analogues endowed with dual Carbonic Anhydrase and VEGFR\u20112 inhibitory activities. J Med Chem 66(15):10558\u201310578. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00721","journal-title":"J Med Chem"},{"issue":"13","key":"11543_CR22","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1021\/acs.jmedchem.0c00636","volume":"63","author":"E Berrino","year":"2020","unstructured":"Berrino E, Angeli A, Zhdanov DD, Kiryukhina AP, Milaneschi A, De Luca A, Bozdag M, Carradori S, Selleri S, Bartolucci G, Peat TS, Ferraroni M, Supuran CT, Carta F (2020) Azidothymidine \u201cClicked\u201d into 1,2,3-Triazoles: First report on carbonic anhydrase\u2013telomerase dual-hybrid inhibitors. J Med Chem 63(13):7392\u20137409. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00636","journal-title":"J Med Chem"},{"issue":"23","key":"11543_CR23","doi-asserted-by":"publisher","first-page":"10692","DOI":"10.1021\/acs.jmedchem.6b01389","volume":"59","author":"A Nocentini","year":"2016","unstructured":"Nocentini A, Ferraroni M, Carta F, Ceruso M, Gratteri P, Lanzi C, Masini E, Supuran CT (2016) Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations. J Med Chem 59(23):10692\u201310704. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01389","journal-title":"J Med Chem"},{"issue":"3","key":"11543_CR24","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1021\/acs.jmedchem.4c02830","volume":"68","author":"AK El-Damasy","year":"2025","unstructured":"El-Damasy AK, Kim HJ, Faisal M, Angeli A, Elsawi AE, Eldehna WM, Supuran CT, Keum G (2025) Novel N-(3-(1-(4-sulfamoylphenyl)triazol-4-yl)phenyl)benzamide derivatives as potent carbonic anhydrase inhibitors with broad-spectrum anticancer activity: leveraging tail and dual-tail approaches. J Med Chem 68(3):3764\u20133781. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02830","journal-title":"J Med Chem"},{"issue":"18","key":"11543_CR25","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1016\/j.bmc.2016.06.052","volume":"24","author":"M Bozdag","year":"2016","unstructured":"Bozdag M, Alafeefy AM, Carta F, Ceruso M, Al-Tamimi A-MS, Al-Kahtani AA, Alasmary FAS, Supuran CT (2016) Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties. Bioorg Med Chem 24(18):4100\u20134107. https:\/\/doi.org\/10.1016\/j.bmc.2016.06.052","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"11543_CR26","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/j.bmc.2017.03.054","volume":"25","author":"M Bozdag","year":"2017","unstructured":"Bozdag M, Alafeefy AM, Altamimi AM, Carta F, Supuran CT, Vullo D (2017) Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII. Bioorg Med Chem 25(10):2782\u20132788. https:\/\/doi.org\/10.1016\/j.bmc.2017.03.054","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"11543_CR27","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1080\/14756366.2020.1722121","volume":"35","author":"AS El-Azab","year":"2020","unstructured":"El-Azab AS, Abdel-Aziz AAM, Ahmed HEA, Bua S, Nocentini A, AlSaif NA, Obaidullah AJ, Hefnawy MM, Supuran CT (2020) Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 35(1):598\u2013609. https:\/\/doi.org\/10.1080\/14756366.2020.1722121","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11543_CR28","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s490930","author":"MM Al-Sanea","year":"2024","unstructured":"Al-Sanea MM, Hafez HM, Mohamed AA, El-Shafey HW, Elgazar AA, Tawfik SS, Ewes WA, Hussein S, Alsahli TG, Hamdi A (2024) Design, synthesis, pharmacological evaluation of quinazolin-4 (3 H)-ones bearing urea functionality as potential VEGFR-2 inhibitors. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/dddt.s490930","journal-title":"Drug Des Devel Ther"},{"issue":"36","key":"11543_CR29","doi-asserted-by":"publisher","first-page":"26325","DOI":"10.1039\/D4RA04828H","volume":"14","author":"SS Tawfik","year":"2024","unstructured":"Tawfik SS, Hamdi A, Ali AR, Elgazar AA, El-Shafey HW, El-Azab AS, Bakheit AH, Hefnawy MM, Ghabbour HA, Abdel-Aziz AA-M (2024) S-Alkylated quinazolin-4 (3 H)-ones as dual EGFR\/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study. RSC Adv 14(36):26325\u201326339","journal-title":"RSC Adv"},{"key":"11543_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105710","volume":"122","author":"A Hamdi","year":"2022","unstructured":"Hamdi A, El-Shafey HW, Othman DI, El-Azab AS, AlSaif NA, Abdel-Aziz AA-M (2022) Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: molecular modeling studies. Bioorg Chem 122:105710","journal-title":"Bioorg Chem"},{"key":"11543_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108526","volume":"161","author":"HW El-Shafey","year":"2025","unstructured":"El-Shafey HW, Al-Sanea MM, Elnagar MR, Gendy AM, Serag MI, Almatary AM, Khalaf MA, Abdulla M-H, Alhassan NS, Mohammed M-AV, Eldehna WM, Hamdi A (2025) Design and synthesis of novel 2-S-alkylated Quinazolinones as dual BRAFV600E and EGFR inhibitors in melanoma: mechanistic insights from apoptosis and cell cycle modulation. Bioorg Chem 161:108526. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108526","journal-title":"Bioorg Chem"},{"key":"11543_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103987","volume":"101","author":"HW El-Shafey","year":"2020","unstructured":"El-Shafey HW, Gomaa RM, El-Messery SM, Goda FE (2020) Synthetic approaches, anticancer potential, HSP90 inhibition, multitarget evaluation, molecular modeling and apoptosis mechanistic study of thioquinazolinone skeleton: promising antibreast cancer agent. Bioorg Chem 101:103987. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103987","journal-title":"Bioorg Chem"},{"key":"11543_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107437","volume":"148","author":"NFM El Hamaky","year":"2024","unstructured":"El Hamaky NFM, Hamdi A, Bayoumi WA, Elgazar AA, Nasr MNA (2024) Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: design, synthesis, and molecular docking study. Bioorg Chem 148:107437. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107437","journal-title":"Bioorg Chem"},{"key":"11543_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102956","volume":"88","author":"AM Soliman","year":"2019","unstructured":"Soliman AM, Ghorab MM (2019) Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3,4-dihydroquinazolin-2-yl)thio]acetamide derivatives as anticancer and radiosensitizing agents. Bioorg Chem 88:102956. https:\/\/doi.org\/10.1016\/j.bioorg.2019.102956","journal-title":"Bioorg Chem"},{"key":"11543_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103422","volume":"94","author":"HA Mahdy","year":"2020","unstructured":"Mahdy HA, Ibrahim MK, Metwaly AM, Belal A, Mehany ABM, El-Gamal KMA, El-Sharkawy A, Elhendawy MA, Radwan MM, Elsohly MA, Eissa IH (2020) Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers. Bioorg Chem 94:103422. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103422","journal-title":"Bioorg Chem"},{"key":"11543_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2025.118515","volume":"133","author":"NFM El Hamaky","year":"2026","unstructured":"El Hamaky NFM, Hamdi A, Bayoumi WA, Elgazar AA, Nasr MNA (2026) Design, synthesis, and biological evaluation of quinazoline\u2013benzohydrazide and quinazoline\u2013benzothiazole hybrids uncovering a dual EGFR\/VEGFR-2 inhibitor with pronounced cytotoxic activity against triple-negative breast Cancer. Bioorg Med Chem 133:118515. https:\/\/doi.org\/10.1016\/j.bmc.2025.118515","journal-title":"Bioorg Med Chem"},{"key":"11543_CR37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molstruc.2015.12.007","volume":"1108","author":"M Hagar","year":"2016","unstructured":"Hagar M, Soliman SM, Ibid F, El Ashry ESH (2016) Synthesis, molecular structure and spectroscopic studies of some new quinazolin-4(3H)-one derivatives; an account on the N- versus S-Alkylation. J Mol Struct 1108:667\u2013679. https:\/\/doi.org\/10.1016\/j.molstruc.2015.12.007","journal-title":"J Mol Struct"},{"issue":"8","key":"11543_CR38","doi-asserted-by":"publisher","first-page":"8873","DOI":"10.1021\/acs.jmedchem.5c00526","volume":"68","author":"MA Zeidan","year":"2025","unstructured":"Zeidan MA, Alkabbani MA, Giovannuzzi S, Khaleel EF, El-Hamaky AA, Khattab NA, Badi R, Abubakr A, Hamdy AM, Fares M, Tawfik HO, Supuran CT, Eldehna WM, Shaldam MA (2025) Shooting an arrow against convulsion: novel triazole-grafted benzenesulfonamide derivatives as carbonic Anhydrase II and VII inhibitors. J Med Chem 68(8):8873\u20138893. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c00526","journal-title":"J Med Chem"},{"issue":"19","key":"11543_CR39","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1016\/j.bmc.2014.08.015","volume":"22","author":"AM Alafeefy","year":"2014","unstructured":"Alafeefy AM, Ceruso M, Al-Tamimi A-MS, Del Prete S, Capasso C, Supuran CT (2014) Quinazoline\u2013sulfonamides with potent inhibitory activity against the \u03b1-carbonic anhydrase from Vibrio cholerae. Bioorg Med Chem 22(19):5133\u20135140. https:\/\/doi.org\/10.1016\/j.bmc.2014.08.015","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"11543_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2234665","volume":"38","author":"MH ElNaggar","year":"2023","unstructured":"ElNaggar MH, Elgazar AA, Gamal G, Hamed SM, Elsayed ZM, El-Ashrey MK, Abood A, El Hassab MA, Soliman AM, El-Domany RA, Badria FA, Supuran CT, Eldehna WM (2023) Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease. J Enzyme Inhib Med Chem 38(1):2234665. https:\/\/doi.org\/10.1080\/14756366.2023.2234665","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11543_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107881","volume":"153","author":"WAA Fadaly","year":"2024","unstructured":"Fadaly WAA, Mohamed FEA, Nemr MTM, Sayed AM, Khalil RG, Zidan TH (2024) Novel benzenesulfonamide derivatives as potential selective carbonic anhydrase IX, XII inhibitors with anti-proliferative activity: design, synthesis and in silico studies. Bioorg Chem 153:107881. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107881","journal-title":"Bioorg Chem"},{"issue":"12","key":"11543_CR42","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1021\/acsmedchemlett.4c00438","volume":"15","author":"AH Abd El-Haleem","year":"2024","unstructured":"Abd El-Haleem AH, Kassem MAE-k, Elnagar MR, Abbas SES, El Kerdawy AM, Farouk AKBAW (2024) Furan- and furopyrimidine-based derivatives: synthesis, VEGFR-2 inhibition, and in vitro cytotoxicity. ACS Med Chem Lett 15(12):2150\u20132157. https:\/\/doi.org\/10.1021\/acsmedchemlett.4c00438","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"11543_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70116","volume":"86","author":"HI Abdelaal","year":"2025","unstructured":"Abdelaal HI, Mohamed AR, Elnagar MR, Giovannuzzi S, Fahim SH, Abdel-Aziz HA, Supuran CT, Abou-Seri SM (2025) Oxindole\u2013coumarin hybrids with broad-spectrum anticancer activity: apoptosis induction and selective CA IX\/XII targeting. Drug Dev Res 86(4):e70116. https:\/\/doi.org\/10.1002\/ddr.70116","journal-title":"Drug Dev Res"},{"key":"11543_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108921","volume":"164","author":"RA Hassan","year":"2025","unstructured":"Hassan RA, Mahmoud Z, Elmaaty AA, Elnagar MR, Abdou AM, El-Haleem AHA, Hamed MIA (2025) Design, synthesis, and anticancer evaluation of new quinazoline hybrids: DNA intercalation, topoisomerase II\u03b1 inhibition, and in silico studies. Bioorg Chem 164:108921. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108921","journal-title":"Bioorg Chem"},{"issue":"45","key":"11543_CR45","doi-asserted-by":"publisher","first-page":"11225","DOI":"10.1021\/ja9621760","volume":"118","author":"WL Jorgensen","year":"1996","unstructured":"Jorgensen WL, Maxwell DS, Tirado-Rives J (1996) Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 118(45):11225\u201311236. https:\/\/doi.org\/10.1021\/ja9621760","journal-title":"J Am Chem Soc"},{"issue":"17","key":"11543_CR46","doi-asserted-by":"publisher","first-page":"9545","DOI":"10.1073\/pnas.161301298","volume":"98","author":"DA Whittington","year":"2001","unstructured":"Whittington DA, Waheed A, Ulmasov B, Shah GN, Grubb JH, Sly WS, Christianson DW (2001) Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells. Proc Natl Acad Sci U S A 98(17):9545\u20139550","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11543_CR47","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ejmech.2018.03.024","volume":"150","author":"A Vallone","year":"2018","unstructured":"Vallone A, D\u2019Alessandro S, Brogi S, Brindisi M, Chemi G, Alfano G, Lamponi S, Lee SG, Jez JM, Koolen KJM, Dechering KJ, Saponara S, Fusi F, Gorelli B, Taramelli D, Parapini S, Caldelari R, Campiani G, Gemma S, Butini S (2018) Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues. Eur J Med Chem 150:698\u2013718. https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.024","journal-title":"Eur J Med Chem"},{"issue":"6","key":"11543_CR48","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1039\/C9FO00265K","volume":"10","author":"ER da Silva","year":"2019","unstructured":"da Silva ER, Brogi S, Lucon-J\u00fanior JF, Campiani G, Gemma S, Maquiaveli CdC (2019) Dietary polyphenols rutin, taxifolin and quercetin related compounds target Leishmania amazonensis arginase. Food Funct 10(6):3172\u20133180. https:\/\/doi.org\/10.1039\/C9FO00265K","journal-title":"Food Funct"},{"issue":"7","key":"11543_CR49","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47(7):1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"11543_CR50","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ejmech.2017.04.057","volume":"135","author":"S Brogi","year":"2017","unstructured":"Brogi S, Fiorillo A, Chemi G, Butini S, Lalle M, Ilari A, Gemma S, Campiani G (2017) Structural characterization of Giardia duodenalis thioredoxin reductase (gTrxR) and computational analysis of its interaction with NBDHEX. Eur J Med Chem 135:479\u2013490. https:\/\/doi.org\/10.1016\/j.ejmech.2017.04.057","journal-title":"Eur J Med Chem"},{"issue":"2","key":"11543_CR51","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79(2):926\u2013935","journal-title":"J Chem Phys"},{"key":"11543_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2019.00574","author":"H Sirous","year":"2019","unstructured":"Sirous H, Chemi G, Gemma S, Butini S, Debyser Z, Christ F, Saghaie L, Brogi S, Fassihi A, Campiani G, Brindisi M (2019) Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2019.00574","journal-title":"Front Chem"},{"issue":"27","key":"11543_CR53","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1021\/j100078a035","volume":"98","author":"DD Humphreys","year":"1994","unstructured":"Humphreys DD, Friesner RA, Berne BJ (1994) A multiple-time-step molecular dynamics algorithm for macromolecules. J Phys Chem 98(27):6885\u20136892. https:\/\/doi.org\/10.1021\/j100078a035","journal-title":"J Phys Chem"},{"issue":"3","key":"11543_CR54","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","volume":"31","author":"WG Hoover","year":"1985","unstructured":"Hoover WG (1985) Canonical dynamics: Equilibrium phase-space distributions. Phys Rev A 31(3):1695\u20131697. https:\/\/doi.org\/10.1103\/PhysRevA.31.1695","journal-title":"Phys Rev A"},{"issue":"5","key":"11543_CR55","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1063\/1.467468","volume":"101","author":"GJ Martyna","year":"1994","unstructured":"Martyna GJ, Tobias DJ, Klein ML (1994) Constant pressure molecular dynamics algorithms. J Chem Phys 101(5):4177\u20134189. https:\/\/doi.org\/10.1063\/1.467468","journal-title":"J Chem Phys"},{"issue":"19","key":"11543_CR56","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103(19):8577\u20138593. https:\/\/doi.org\/10.1063\/1.470117","journal-title":"J Chem Phys"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11543-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11543-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11543-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:46:41Z","timestamp":1791121601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11543-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["11543"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11543-0","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}